Search Results - "Zuber, Patrick Lf"

The Global Vaccine Safety Initiative: enhancing vaccine pharmacovigilance capacity at country level by MAURE, Christine G, DODOO, Alexander N, BONHOEFFER, Jan, ZUBER, Patrick L. F

“…Large-scale immunization programmes now extend to all parts of the world, including least developed countries, where they reach unprecedented numbers of…”
Get full text

Immunization stress-related response – Redefining immunization anxiety-related reaction as an adverse event following immunization by Gold, Michael S., MacDonald, Noni E., McMurtry, C. Meghan, Balakrishnan, Madhava Ram, Heininger, Ulrich, Menning, Lisa, Benes, Oleg, Pless, Robert, Zuber, Patrick L.F.

“…The Council for the International Organizations of Medical Sciences (CIOMS) and WHO working group on pharmacovigilance defines five cause specific AEFI which…”
Get full text

Economic and immunisation safety surveillance characteristics of countries implementing no-fault compensation programmes for vaccine injuries by Mungwira, Randy G., Maure, Christine Guillard, Zuber, Patrick L.F.

“…•There is improved global vaccine safety surveillance and investigative capacity.•As a result, rare but severe vaccine reactions are documented, including in…”
Get full text

Use of a new global indicator for vaccine safety surveillance and trends in adverse events following immunization reporting 2000–2015 by Lei, Jiayao, Balakrishnan, Madhava Ram, Gidudu, Jane F., Zuber, Patrick L.F.

“…Reporting of adverse events following immunization (AEFI) is a key component for functional vaccine safety monitoring system. The aim of our study is to…”
Get full text

The use of web analytics combined with other data streams for tailoring online vaccine safety information at global level: The Vaccine Safety Net’s web analytics project by Gesualdo, Francesco, Marino, Francesco, Mantero, Jas, Spadoni, Andrea, Sambucini, Luigi, Quaglia, Giammarco, Rizzo, Caterina, Sahinovic, Isabelle, Zuber, Patrick L.F., Tozzi, Alberto E.

“…The Vaccine Safety Net’s Web Analytics Project (VSN-WAP) was launched in October 2017 to monitor the behavior of users visiting websites belonging to the VSN,…”
Get full text

Assessment of causality of individual adverse events following immunization (AEFI): A WHO tool for global use by Tozzi, Alberto E, Asturias, Edwin J, Balakrishnan, Madhava Ram, Halsey, Neal A, Law, Barbara, Zuber, Patrick L.F

“…Highlights • We developed a simple tool to support causality assessment of AEFI • The assessment tool is harmonized with the Clinical Immunization Safety…”
Get full text

The science of vaccine safety: Summary of meeting at Wellcome Trust by Plotkin, Stanley A., Offit, Paul A., DeStefano, Frank, Larson, Heidi J., Arora, Narendra Kumar, Zuber, Patrick L.F., Fombonne, Eric, Sejvar, James, Lambert, Paul Henri, Hviid, Anders, Halsey, Neal, Garçon, Nathalie, Peden, Keith, Pollard, Andrew J., Markowitz, Lauri E., Glanz, Jason

“…Vaccines are everywhere hugely successful but are also under attack. The reason for the latter is the perception by some people that vaccines are unsafe…”
Get full text

The Safety of PsA-TT in Pregnancy: An Assessment Performed Within the Navrongo Health and Demographic Surveillance Site in Ghana by Wak, George, Williams, John, Oduro, Abraham, Maure, Christine, Zuber, Patrick L. F., Black, Steven

“…Background. Group A meningococcal disease occurs in large epidemics within the meningitis belt of Africa that includes northern Ghana. Major epidemics in the…”
Get full text

Vaccine safety surveillance in pregnancy in low- and middle-income countries using GAIA case definitions: A feasibility assessment by Stuurman, Anke L., Riera, Margarita, Lamprianou, Smaragda, Perez-Vilar, Silvia, Anderson, Steven A., Mangtani, Punam, Devlieger, Hugo, Verstraeten, Thomas, Zuber, Patrick L.F., Guillard Maure, Christine

“…Global efforts to adequately monitor safety of new vaccines for pregnant women in low and middle-income countries (LMICs) are needed. The Global Alignment of…”
Get full text

Guideline for collection, analysis and presentation of safety data in clinical trials of vaccines in pregnant women by Jones, Christine E, Munoz, Flor M, Spiegel, Hans M.L, Heininger, Ulrich, Zuber, Patrick L.F, Edwards, Kathryn M, Lambach, Philipp, Neels, Pieter, Kohl, Katrin S, Gidudu, Jane, Hirschfeld, Steven, Oleske, James M, Khuri-Bulos, Najwa, Bauwens, Jorgen, Eckert, Linda O, Kochhar, Sonali, Bonhoeffer, Jan, Heath, Paul T

“…Abstract Vaccination during pregnancy is increasingly being used as an effective approach for protecting both young infants and their mothers from serious…”
Get full text

Effectively introducing a new meningococcal A conjugate vaccine in Africa: The Burkina Faso experience by Djingarey, Mamoudou H, Barry, Rodrigue, Bonkoungou, Mete, Tiendrebeogo, Sylvestre, Sebgo, Rene, Kandolo, Denis, Lingani, Clement, Preziosi, Marie-Pierre, Zuber, Patrick L.F, Perea, William, Hugonnet, Stéphane, Dellepiane de Rey Tolve, Nora, Tevi-Benissan, Carole, Clark, Thomas A, Mayer, Leonard W, Novak, Ryan, Messonier, Nancy E, Berlier, Monique, Toboe, Desire, Nshimirimana, Deo, Mihigo, Richard, Aguado, Teresa, Diomandé, Fabien, Kristiansen, Paul A, Caugant, Dominique A, LaForce, F. Marc

“…Highlights ► Introduction of a new meningitis vaccine in Burkina Faso in 2010 was a huge success. ► More than 11 million Burkinabe (100% target population)…”
Get full text

Contributions and challenges for worldwide vaccine safety: The Global Advisory Committee on Vaccine Safety at 15 years by Asturias, Edwin J, Wharton, Melinda, Pless, Robert, MacDonald, Noni E, Chen, Robert T, Andrews, Nicholas, Salisbury, David, Dodoo, Alexander N, Hartigan-Go, Kenneth, Zuber, Patrick L.F

“…Abstract In 1999, the Global Advisory Committee on Vaccine Safety (GACVS) was established by the World Health Organization (WHO) to provide independent…”
Get full text

Building capacity for active surveillance of vaccine adverse events in the Americas: A hospital-based multi-country network by Bravo-Alcántara, Pamela, Pérez-Vilar, Silvia, Molina-León, Helvert Felipe, Sturkenboom, Miriam, Black, Steven, Zuber, Patrick L.F., Maure, Christine, Castro, Jose Luis, Castellano, Vanesa E., Chiarvetti, Lucia, Falcó, Adriana, Gentile, Angela, Guirau, Karina, Carrega, Maria Eugenia Pérez, Rasjido, Susana, Testino, Sofía, Vizzotti, Carla, Avendaño, Marcela, González, Marcela, Lagos, Rosanna, Maturana, Marcelo, Muñoz, Fernando, Saldaña, Adiela, Soza, Guillermo, Álvarez-Olmos, Martha, Sastoque, Luz Amparo, Mezerville, Marcela Hernández-de, Machado, Vicenta, Roverssi, Ileana, Camacho, Angélica Vargas, Luque, Marco Tulio, Mendoza, Liset, Hernández, Renne F. Aquije, Díaz, Maria Esther Castillo, Mamani, Gladys Turpo, Giachetto, Gustavo, Speranza, Noelia, Zunino, Carlos

“…New vaccines designed to prevent diseases endemic in low and middle-income countries are being introduced without prior utilization in countries with robust…”
Get full text

Active Surveillance for Adverse Events After a Mass Vaccination Campaign With a Group A Meningococcal Conjugate Vaccine (PsA-TT) in Mali by Vannice, Kirsten S., Keita, Modibo, Sow, Samba O., Durbin, Anna P., Omer, Saad B., Moulton, Lawrence H., Yaméogo, Téné M., Zuber, Patrick L. F., Onwuchekwa, Uma, Sacko, Massambou, Diomandé, Fabien V. K., Halsey, Neal A.

“…Background. The monovalent meningococcal A conjugate vaccine (PsA-TT, MenAfriVac) was developed for use in the "meningitis belt" of sub-Saharan Africa. Mali…”
Get full text

Adverse events following immunization during mass vaccination campaigns at first introduction of a meningococcal A conjugate vaccine in Burkina Faso, 2010 by Ouandaogo, Claude-Roger, Yaméogo, Téné M, Diomandé, Fabien V.K, Sawadogo, Charles, Ouédraogo, Bassirou, Ouédraogo-Traoré, Rasmata, Pezzoli, Lorenzo, Djingarey, Mamoudou H, Mbakuliyemo, Nehémie, Zuber, Patrick L.F

“…Highlights ► Health problems detected were comparable with baseline data of the districts. ► Documented safety profile consistent with monovalent PS conjugate…”
Get full text

Lessons Learned From Enhancing Vaccine Pharmacovigilance Activities During PsA-TT Introduction in African Countries, 2010–2013 by Diomandé, Fabien V. K., Yaméogo, Téné M., Vannice, Kirsten S., Preziosi, Marie-Pierre, Viviani, Simonetta, Ouandaogo, Claude-Roger, Keita, Modibo, Djingarey, Mamoudou H., Mbakuliyemo, Nehemie, Akanmori, Bartholomew Dicky, Sow, Samba O., Zuber, Patrick L. F.

“…Background. The rollout of the group A meningococcal vaccine, PsA-TT, in Africa's meningitis belt countries represented the first introduction of a vaccine…”
Get full text

Research priorities regarding rotavirus vaccine and intussusception: A meeting summary by Tate, Jacqueline E, Steele, A. Duncan, Bines, Julie E, Zuber, Patrick L.F, Parashar, Umesh D

“…Highlights ► In 2009, WHO recommended inclusion of rotavirus vaccines in the routine childhood vaccine programs of all countries. ► Available rotavirus…”
Get full text

Pediatric Appropriate Evaluation Protocol for India (PAEP-India): Tool for Assessing Appropriateness of Pediatric Hospitalization by Das, Manoja Kumar, Arora, Narendra Kumar, Poluru, Ramesh, Seth, Anju, Aggarwal, Anju, Dubey, Anand Prakash, Goyal, Pc, Gathwala, Geeta, Malik, Ashraf, Goel, Anil Kumar, Chakravarty, Aparna, Arya, Sugandha, Upadhyay, Amit, Gupta, Madhur, Mathew, Thomas, Pillai, Rajamohanan K, Mathai, John, Manivasagan, Sivamani, Ramesh, S, Aggarwal, Mahesh Kumar, Maure, Chsirtine G, Zuber, Patrick Lf

“…Objectives To develop and assess Pediatric Appropriateness Evaluation Protocol for India (PAEP-India) for inter-rater reliability and appropriateness of…”
Get full text

Monitoring adverse events following immunization with a new conjugate vaccine against group A meningococcus in Niger, September 2010 by Chaibou, Maman S, Bako, Harouna, Salisou, Laouali, Yaméogo, Téné M, Sambo, Mariama, Kim, Sung Hye, Djingarey, Mamoudou H, Zuber, Patrick L.F, Perea, William A, Pezzoli, Lorenzo

“…Highlights ► A new conjugate vaccine against meningitis A was introduced in Niger in 2010. ► We conducted surveillance of adverse events following…”
Get full text

Sustaining GAVI-supported vaccine introductions in resource-poor countries by Zuber, Patrick L.F, El-Ziq, Ibrahim, Kaddar, Miloud, Ottosen, Ann E, Rosenbaum, Katinka, Shirey, Meredith, Kamara, Lidija, Duclos, Philippe

“…Abstract Since 2000, GAVI provided essential support for an unprecedented increase in the use of hepatitis B (HepB) and Haemophilus influenzae (Hib) containing…”
Get full text